Category: Ophthalmology
Global Ophthalmology
-
Ophthalmology Drugs Market by Molecule (Faricimab, Aflibercept, Ranibizumab), Modality (Monoclonal Antibodies & Fusion Proteins), RoA (Intravitreal, Topical), Indication (AMD, Diabetic Retinopathy (DR), DME), End User - Global Forecast to 2030
... market has primarily been driven by the increasing prevalence of age-related eye diseases and the availability of several key therapies that address these conditions. Additionally, a robust pipeline of new drugs across various treatment modalities ... Read More
-
Global Ophthalmic Implants Market - Focused Insights 2025-2030
... into the ophthalmology sector. This transaction is valued at around $381 million. Alimera Sciences was offered 2 ophthalmic implants that treat posterior eye diseases. In 2023, Carl Zeiss Meditech acquired DORC- Dutch Ophthalmic Research Centers ... Read More
-
The 2026-2031 World Outlook for Advanced Ophthalmology Technologies
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Bacterial Conjunctivitis Drugs
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Corneal Ulcer Treatments
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Cataract Surgical Devices
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
2025 Diseases of the Eye and Adnexa Global Market Size & Growth Report with Updated Country Recession Risk Forecasts
... East), 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling diseases of the eye ... Read More
-
The 2026-2031 World Outlook for Anti-Vascular Endothelial Growth Factor Therapy (Anti-VEGF) for Non-Infectious Macular Edema
... industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge ... Read More
-
The 2026-2031 World Outlook for Corneal Implants
... (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which ... Read More
-
The 2026-2031 World Outlook for Cataract Surgery Devices
... question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models ... Read More
-
The 2026-2031 World Outlook for Anti-Vascular Endothelial Growth Factor (Anti-VEGF) Diabetic Macular Edema Treatments
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
Retinitis Pigmentosa Global Market Opportunities And Strategies To 2034
... it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies. Understand how the market is being affected by ... Read More
-
Global Age-Related Macular Degeneration Market - 2025-2033
... The global age-related macular degeneration (AMD) treatment market is primarily driven by rising prevalence. Moreover, due to advancements in diagnostics, the diagnosis rate has significantly increased, along with which, the treatment rate has seen positive ... Read More
-
Optical Coherence Tomography (OCT) for Ophthalmology
... reach US$1.1 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2024-2030. Conventional OCT Systems, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and ... Read More
-
Ophthalmic Ultrasound Systems
... at a CAGR of 3.9% over the analysis period 2024-2030. Portable, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$2.4 Billion by the end of the ... Read More
-
Glaucoma Surgery Devices
... at a CAGR of 21.0% over the analysis period 2024-2030. Traditional, one of the segments analyzed in the report, is expected to record a 20.8% CAGR and reach US$3.1 Billion by the end of the ... Read More
-
Ophthalmology Picture Archiving and Communication Systems
... reach US$211.3 Million by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Integrated PACS, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach ... Read More
-
Ophthalmic Pharmaceutical Drugs
... at a CAGR of 3.6% over the analysis period 2024-2030. Anti-VEGF Agents, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$34.3 Billion by the end of ... Read More
-
Neuroprosthetics
... 11.9% over the analysis period 2024-2030. Spinal Cord Stimulation, one of the segments analyzed in the report, is expected to record a 13.2% CAGR and reach US$11.7 Billion by the end of the analysis period. ... Read More
-
Ophthalmic Femtosecond Lasers
... at a CAGR of 4.6% over the analysis period 2024-2030. Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$666.4 Million by the end ... Read More
-
Diabetes Associated Ophthalmic Treatment
... 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Diabetic Ophthalmic Drugs, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$28.9 Billion by ... Read More
-
Vitreous Tamponades
... CAGR of 3.0% over the analysis period 2024-2030. Gaseous Tamponades, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$50.9 Million by the end of the analysis ... Read More
-
Ophthalmic Lasers
... CAGR of 5.0% over the analysis period 2024-2030. Femtosecond Lasers, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$757.4 Million by the end of the analysis ... Read More
-
Global Thyroid Gland Disorders: Diagnostics and Treatment Market
... for the forecast period of 2026 through 2030. The market is segmented by type of disease, product type, end user and region. The disease types are segmented into hypothyroidism, hyperthyroidism, thyroid cancer, and others. Product ... Read More
-
2025 Global Forecast for Micro-Invasive Glaucoma Implants Market (2026-2031 Outlook)-High Tech Outlook Report
... or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx billion ... Read More
Research Assistance
